Skip to main content
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.500
-0.004 (-0.70%)
Dec 20, 2024, 4:00 PM EST - Market closed

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $1.14M in the quarter ending September 30, 2024, a decrease of -54.87%. This brings the company's revenue in the last twelve months to $9.78M, up 35.86% year-over-year. In the year 2023, Bolt Biotherapeutics had annual revenue of $7.88M with 37.48% growth.

Revenue (ttm)
$9.78M
Revenue Growth
+35.86%
P/S Ratio
1.95
Revenue / Employee
$97,790
Employees
100
Market Cap
19.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 64.91M
Retractable Technologies 38.27M
Bionano Genomics 33.33M
BioLineRx 21.99M
Affimed 6.29M
Revenue Rankings

BOLT News

More News